Supreme Court Upholds Acquittal, Holds Investigating Officer Cannot Create Evidence || Supreme Court: NDPS Prosecution Cannot Be Quashed Solely Over Co-Accused’s Disclosure || SC: Tax Classification Depends on Goods' Form at Sale, not their End Use || Delhi High Court: No Material Showing Delhi Police Compromised the 2020 Riots Probe || Madras HC Suggests Mandatory Attachment of Properties Suspected to Be Proceeds of Corruption || P&H High Court: Demolition After Lawyer Flagged Corruption Appears Aimed at Silencing Him || Calcutta High Court: Contempt Proceedings Cannot Be Used to Challenge Orders or Attack Judges || Orissa High Court: Marriage Need Not Be Preserved When the Relationship Has Substantially Eroded || SC: CIRP Can Continue Despite Fraudulent Insolvency Plea That Triggered It || Delhi HC: Senior Citizen May Seek Eviction of Daughter-in-Law for Ill-Treatment

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :